CTKB
Cytek Biosciences, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$5.30
+1.73%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- -$0.07
- Revenue estimate
- $52.9M
Latest reported
- Last report date
- Aug 5, 2026
- EPS actual
- -$0.05
- EPS estimate
- -$0.09
- Revenue actual
- $48.1M
- Revenue estimate
- $47.3M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -13.4%
- Revenue beats (12Q)
- 5
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 5, 2026 | -$0.09 | -$0.05 | Beat 46.43% | $48.1M |
| May 7, 2026 | -$0.08 | -$0.12 | Miss -50.00% | $44.1M |
| Nov 5, 2025 | $0.01 | -$0.01 | Miss -200.00% | $52.3M |
| Aug 6, 2025 | -$0.02 | $0.01 | Beat 150.00% | $45.6M |
| May 8, 2025 | -$0.04 | -$0.09 | Miss -125.00% | $41.5M |
| Feb 27, 2025 | $0.05 | $0.07 | Beat 40.00% | $57.5M |
| Mar 13, 2024 | $0.03 | $0.07 | Beat 133.33% | $58.2M |
| Feb 28, 2023 | $0.05 | $0.07 | Beat 40.00% | $164.0M |
| Aug 10, 2022 | $0.02 | $0.03 | Beat 79.96% | $40.2M |
| Feb 23, 2022 | $0.04 | $0.05 | Beat 19.99% | $38.9M |
| Sep 3, 2021 | — | $0.02 | — | $30.4M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026